1. Clinical record {#sec1}
==================

A 64 year old man presented with haemoptysis and refractory hypoxia (p02 41 mmHg on FiO~2~ 0.8) following a short airflight. He was transferred for palliation closer to home. His history included 50 pack years smoking, asbestos exposure and weight loss. CT thorax (See [Fig. 1](#fig1){ref-type="fig"}) revealed extensive, dense consolidation of both lungs, bilateral hilar and subcarinal adenopathy, and centrilobular emphysema, but with no distant metastases evident. Sputum cytology reported atypical cells, favouring adenocarcinoma. He was polycythaemic with a haemoglobin of 203 g/L. He received antibiotics to treat any infective component, and glucocorticoids but without significant improvement. His oxygen saturations remained between 70 and 80% despite high flow oxygen. He was too unwell for further invasive investigations such as biopsy, or treatment such as chemotherapy (unknown ALK and EGFR status). He sought palliation and was discharged home with home oxygen approximately 10 L/min achieved via OxyMask with 2 connected oxygen concentrators.

8 months after initial diagnosis, he remained hypoxic, although his general condition remained stable (ECOG performance status 3) with no evidence of other end organ dysfunction. He was re-evaluated with CT scans, respiratory function tests, arterial blood gases, VQ scan, bubble contrast echocardiogram and a 100% oxygen shunt study. The calculated shunt fraction was 25% (p02 54.1 on 100% O~2~, PCO2 38.9, SaO~2~ 88%. Hb195) There was no evidence of extra-pulmonary shunting. The VQ scan revealed marked perfusion to the unventilated right lower lobe, consistent with significant intrapulmonary shunting. Distant metastases were not detected and there was only marginal progression of his extensive consolidation to both lungs. Given his poor pulmonary reserve, biopsy for EGFR and ALK status was not undertaken. However after multidisciplinary discussion, the feasibility of a palliative procedure to reduce the shunt and hopefully improve his oxygenation and quality of life was considered.

With informed consent, he underwent pulmonary angiography with intrapulmonary catheterisation and temporary occlusion of the right inferior pulmonary artery which improved oxygen saturations from 79% to 82%. Subsequent embolisation of his right lower lobe pulmonary artery with an 18 mm Amplatzer vascular plug II device was then performed. (See [Fig. 2](#fig2){ref-type="fig"}) He improved clinically although the dramatic improvement in oxygenation was not sustained with SaO~2~ decreasing to 78--81% on 10 L O~2~ within 1 day. Repeat VQ scanning 3 days later confirmed reduced perfusion of the non-ventilated posterobasal and lateral basal segments of the right lower lobe compared with the pre-procedural scan. However there was still flow to the superior and anterobasal segments of the right lower lobe. (See [Fig. 3](#fig3){ref-type="fig"}). He remained stable and was discharged home 5 days post procedure. He reported marked symptomatic improvement in his ability to carry out activities of daily living. His home monitored peripheral SaO~2~ were between 71 and 96 % with a median of 86%. He subsequently died 3 months later from a complicated pneumothorax and pulmonary embolism.

Autopsy revealed extensive LPA involving all lobes of both lungs as well as hilar, mediastinal and retrosternal lymph nodes. There was a right upper lobe pulmonary embolus and a left upper lobe abscess colonised by aspergillus. The Amplatzer vascular plug was identified within a large vessel at the boundary of the right lower and middle lobes, with no evidence it contributed to his death.

2. Discussion {#sec2}
=============

This is the first report we are aware of to use this minimally invasive, palliative procedure to improve shunting within a lung adenocarcinoma (lepidic predominant). There are few literature reports of LPA with refractory hypoxia from intrapulmonary shunting [@bib1; @bib2; @bib3; @bib4; @bib5; @bib6; @bib7]. 5 reports have described 10 patients who underwent palliative surgery to correct the intrapulmonary shunt and hypoxia (see [Table 1](#tbl1){ref-type="table"}) [@bib1; @bib2; @bib3; @bib4; @bib5] Survival post resection ranged from 21 days to 24 months [@bib1; @bib2; @bib3; @bib4; @bib5]. Some underwent chemotherapy and/or radiation therapy [@bib1; @bib2; @bib3; @bib4; @bib5]. One patient even proceeded to subsequent lung transplantation [@bib3]. Intrapulmonary shunting has also been reported in squamous cell carcinoma and carcinoid of the lung [@bib8; @bib9; @bib10; @bib11].

It is uncertain why our patient\'s initial dramatic oxygenation improvement was not sustained. Imaging did not reveal significant movement of the Amplatzer plug. Perhaps with his extensive bilateral lung disease, the moderate perfusion correction to unventilated lung was not enough to clearly demonstrate pO2 improvement. Despite no sustained improvement in oxygen saturation, he felt better and was more able to perform his activities of daily living. Unfortunately formal assessments of quality of life were not undertaken before and after the intervention.

The total cost of the Amplatzer II vascular plug and associated procedural costs is estimated at \$1500, and bed costs approximately \$2000. His home oxygen usage was unchanged but the palliative benefits of improving quality of life must not be discounted. Compared with major palliative thoracic surgical resection, intravascular stenting is less invasive and should be associated with shorter hospital stays.

Although life expectancy is unlikely to change, this procedure may also have a role as bridging therapy while awaiting more definitive treatment for selected cases with minimal disease.

3. Conclusion {#sec3}
=============

This is a novel, minimally invasive approach to lung adenocarcinoma with lepidic pattern with refractory hypoxia from intrapulmonary shunting for symptom relief. Given the rarity of this condition, further studies with multi-centre collaboration are needed.
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![a) CT coronal view, b) CT axial view.](gr1){#fig1}

![a) Pre vascular plug, b) vascular plug profile, c) post.](gr2){#fig2}

![VQ scan a) before and b) after procedure.](gr3){#fig3}

###### 

Published cases of intrapulmonary shunting from lung cancer causing refractory hypoxia.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Authors                        Age (years) Sex                  Cancer                        ECOG   Initial PO2 (mmHg)              P02 after surgery                           Treatment                              Survival
  ------------------------------ -------------------------------- ----------------------------- ------ ------------------------------- ------------------------------------------- -------------------------------------- ------------------------------------------------------------------------------
  Barlesi et al. [@bib1] 2001    53 M                             LPA                           1      54 on 5L02                      133 on 5L02                                 Surgery + Chemo                        3 months

                                 54 F                             LPA                           1      53 on 5L02                      125 on 5L 02                                Surgery + Chemo                        12 months

                                 68 M                             LPA                           2      46 on 5L02                      102 on 5L02                                 Surgery                                21 days MI complicating pneumonia

                                 46 M                             LPA                           2      49 on 5L 02                     240 on 5L 02                                Surgery + chemo                        18 months

                                 (7 other cases at institution)                                                                        (survival 1--11 months. Mean 6.4 months)\                                          
                                                                                                                                       From respiratory failure                                                           

  Chetty et al. [@bib2] 1997     71 M                             LPA                                  46 on RA                        63 on RA                                    Surgery + XRT                          6 months from stroke

  Falcoz et al. [@bib3] 2009     68 M                             LPA                                  45 on RA                        72 on RA                                    Surgery + Chemo                        24 months

                                 54 M                             LPA                                  57 on RA                        75 on RA                                    Surgery + subsequent Lung transplant   16 months later, post op after lung transplantation due to colon perforation

                                 63 M                             LPA                                  55 on 15L 02                    109 on RA                                   Neoadjuvant chemo then surgery         Alive 6 months after surgery

  Fishman et al. [@bib4] 1974    64 M                             LPA                                  21 on RA                        55 to 68 on RA                              Surgery                                8 months

  Sarlin et al. [@bib5] 1980     68 M                             LPA                                  58 on RA                        80 on RA                                    Surgery                                Alive 7 months later

  Vanoyan et al. [@bib6] 1998                                     LPA                                                                                                                                                     

  Venkata et al. [@bib7] 2009    74 M                             LPA                                  49 on 2L02 and 52 on 100%O~2~                                                                                      Ventilator support withdrawn after 30 days

  Wartski et al. [@bib8] 1998    68 M                             SCC                                  47 on RA\                       79.5 on RA                                  XRT                                    Alive 1 year later
                                                                                                       84.7 on 100%O~2~                                                                                                   

  Kikano et al. [@bib9] 1994                                      ? Proximal bronchial cancer          52                                                                          Surgery                                

  Hussain et al. [@bib10] 1994   36 M                             Carcinoid                            6.14 kPa on RA (46 mmHg)                                                    Chemo                                  Alive 1 year later

  Lee et al. [@bib11] 1999       37 F                             carcinoid                            46 on RA\                                                                                                          
                                                                                                       71 on 100%O~2~                                                                                                     
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

M = male, F = female, LPA = lepidic predominant adenocarcinoma (formerly known as bronchioalveolar adenocarcinoma), SCC = squamous cell carcinoma. ECOG = Eastern Cooperative Oncology Group Performance Status, RA = room air, O~2~ = oxygen, Chemo = chemotherapy, XRT = radiation therapy, MI = myocardial infarction.

[^1]: Formerly of the Department of Internal Medicine, The Prince Charles Hospital, Rode Rd, Chermside QLD 4032, Australia.
